Close

Form 3 INVO Bioscience, Inc. For: Jun 14 Filed by: Goren Andrea

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. LVS
2. TSM
3. CSX
4. SPY
5. NFLX
6. UAL
7. ALK
8. EFX
9. TSLA
10. INFY


June 21, 2021 6:12 PM EDT
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Goren Andrea
(Last) (First) (Middle)
C/O INVO BIOSCIENCE, INC.
5582 BROADCAST COURT
(Street)
SARASOTA FL 34240
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/14/2021 		3. Issuer Name and Ticker or Trading Symbol
INVO Bioscience, Inc. [ INVO ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 12,500
D
 
Common Stock 45,709
I
Via Andax LLC
Common Stock (1) 5,000
D
 
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option   (2) 06/13/2031 Common Stock 72,500 5.13 D  
Stock Option   (3) 08/10/2030 Common Stock 162,500 5.76 D  
Explanation of Responses:
1. Represents an award of restricted stock units, which vest in substantially equal monthly increments over a period of 12 months from the grant date of June 14, 2021.
2. The option will not commence vesting or be exercisable until the Issuer has sufficient shares available under its 2019 Stock Incentive Plan on January 1, 2022 in accordance with the annual increase provisions contained in Section 4.2 thereunder, at which time 12,083 shares underlying the option will vest and the remainder will vest monthly over a 3-year period.
3. The option vests in monthly increments over a 3-year period from the date of grant.
/s/ Andrea Goren 06/21/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings